이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

암 환자의 생식 건강 프로그램 (EROS)

2026년 9월 14일 업데이트: ECOG-ACRIN Cancer Research Group

EROS: 종양 생존자 내에서 생식 건강 촉진

This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.

연구 개요

상태

모집하지 않고 적극적으로

정황

개입 / 치료

상세 설명

PRIMARY OBJECTIVES:

I. To evaluate the success of the implementation of reproductive health programming (Didactics, Engendering Reproductive Health Within Oncologic Survivorship [EROS] Reproductive Health Assessment and EROS Trial Algorithm) among reproductive aged females (15-55) with cancer.

SECONDARY OBJECTIVES:

I. To assess the degree of discrepancy between patients and their clinicians in estimates of significance of the reproductive health goals for the patient.

II. To evaluate baseline and follow-up reproductive health assessments for trends in reproductive health choices relating to oncofertility, oncocontraception and pregnancy over the 2-year study period.

III. To identify clinical and demographic factors that predict the adequacy of reproductive health care management.

TERTIARY OBJECTIVES:

I. To perform a longitudinal study following endocrine markers of fertility in a cohort of the first 200 registered EROS trial patients who agree to participate.

II. To perform a longitudinal study of sexual function using the Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function survey in all subjects participating in the EROS Trial.

OUTLINE: Participating institutions are randomized to 1 of 2 arms. Patients are assigned to a study arm depending on the institutional assignment.

ARM A: Patients undergo usual standard practice related to reproductive health. ARM B: Patients undergo reproductive health program comprising didactics, reproductive health assessment and navigating algorithm, and network development.

After completion of study intervention, patients are followed up periodically.

연구 유형

중재적

등록 (실제)

434

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

  • 미국
    • Arkansas
      • Jonesboro, Arkansas, 미국, 72401
        • Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
    • Colorado
      • Aurora, Colorado, 미국, 80012
        • Rocky Mountain Cancer Centers-Aurora
      • Boulder, Colorado, 미국, 80304
        • Rocky Mountain Cancer Centers-Boulder
      • Denver, Colorado, 미국, 80204
        • Cancer Center of Colorado at Sloan's Lake
      • Lone Tree, Colorado, 미국, 80124
        • Rocky Mountain Cancer Centers-Sky Ridge
      • Wheat Ridge, Colorado, 미국, 80033
        • SCL Health Lutheran Medical Center
    • Georgia
      • Augusta, Georgia, 미국, 30912
        • Augusta University Medical Center
      • Columbus, Georgia, 미국, 31904
        • John B Amos Cancer Center
    • Hawaii
      • Honolulu, Hawaii, 미국, 96813
        • Queen's Medical Center
      • Honolulu, Hawaii, 미국, 96813
        • Queen's Cancer Cenrer - POB I
      • Honolulu, Hawaii, 미국, 96813
        • Straub Clinic and Hospital
      • Honolulu, Hawaii, 미국, 96813
        • University of Hawaii Cancer Center
      • Honolulu, Hawaii, 미국, 96817
        • Queen's Cancer Center - Kuakini
      • Honolulu, Hawaii, 미국, 96826
        • Kapiolani Medical Center for Women and Children
      • Honolulu, Hawaii, 미국, 96813
        • Hawaii Cancer Care Inc-POB II
      • Honolulu, Hawaii, 미국, 96859
        • Tripler Army Medical Center
      • ‘Aiea, Hawaii, 미국, 96701
        • Pali Momi Medical Center
    • Illinois
      • Chicago, Illinois, 미국, 60612
        • John H Stroger Jr Hospital of Cook County
      • Danville, Illinois, 미국, 61832
        • Carle on Vermilion
      • Effingham, Illinois, 미국, 62401
        • Carle Physician Group-Effingham
      • Mattoon, Illinois, 미국, 61938
        • Carle Physician Group-Mattoon/Charleston
      • Urbana, Illinois, 미국, 61801
        • Carle Cancer Center
      • Urbana, Illinois, 미국, 61801
        • The Carle Foundation Hospital
    • Iowa
      • Clive, Iowa, 미국, 50325
        • Mercy Cancer Center-West Lakes
      • Clive, Iowa, 미국, 50325
        • Medical Oncology and Hematology Associates-West Des Moines
      • Creston, Iowa, 미국, 50801
        • Greater Regional Medical Center
      • Des Moines, Iowa, 미국, 50314
        • Mercy Medical Center - Des Moines
      • Des Moines, Iowa, 미국, 50314
        • Medical Oncology and Hematology Associates-Laurel
      • West Des Moines, Iowa, 미국, 50266
        • Mercy Medical Center-West Lakes
    • Kentucky
      • Lexington, Kentucky, 미국, 40509
        • Saint Joseph Hospital East
      • London, Kentucky, 미국, 40741
        • Saint Joseph London
    • Louisiana
      • Monroe, Louisiana, 미국, 71202
        • Ochsner LSU Health Monroe Medical Center
      • Shreveport, Louisiana, 미국, 71103
        • LSU Health Sciences Center at Shreveport
    • Minnesota
      • Bemidji, Minnesota, 미국, 56601
        • Sanford Joe Lueken Cancer Center
      • Coon Rapids, Minnesota, 미국, 55433
        • Mercy Hospital
      • Edina, Minnesota, 미국, 55435
        • Fairview Southdale Hospital
      • Fridley, Minnesota, 미국, 55432
        • Unity Hospital
      • Maplewood, Minnesota, 미국, 55109
        • Saint John's Hospital - Healtheast
      • Maplewood, Minnesota, 미국, 55109
        • Minnesota Oncology Hematology PA-Maplewood
      • Minneapolis, Minnesota, 미국, 55415
        • Hennepin County Medical Center
      • Minneapolis, Minnesota, 미국, 55407
        • Abbott-Northwestern Hospital
      • Minneapolis, Minnesota, 미국, 55454
        • Health Partners Inc
      • Robbinsdale, Minnesota, 미국, 55422
        • North Memorial Medical Health Center
      • Saint Louis Park, Minnesota, 미국, 55416
        • Park Nicollet Clinic - Saint Louis Park
      • Saint Paul, Minnesota, 미국, 55101
        • Regions Hospital
      • Saint Paul, Minnesota, 미국, 55102
        • United Hospital
      • Shakopee, Minnesota, 미국, 55379
        • Saint Francis Regional Medical Center
      • Stillwater, Minnesota, 미국, 55082
        • Lakeview Hospital
      • Willmar, Minnesota, 미국, 56201
        • Rice Memorial Hospital
      • Woodbury, Minnesota, 미국, 55125
        • Minnesota Oncology Hematology PA-Woodbury
    • Mississippi
      • Oxford, Mississippi, 미국, 38655
        • Baptist Memorial Hospital and Cancer Center-Oxford
    • Nebraska
      • Grand Island, Nebraska, 미국, 68803
        • CHI Health Saint Francis
    • Nevada
      • Henderson, Nevada, 미국, 89052
        • OptumCare Cancer Care at Seven Hills
      • Las Vegas, Nevada, 미국, 89148
        • OptumCare Cancer Care at Fort Apache
      • Las Vegas, Nevada, 미국, 89113
        • HealthCare Partners Medical Group Oncology/Hematology-San Martin
      • Las Vegas, Nevada, 미국, 89128
        • HealthCare Partners Medical Group Oncology/Hematology-Tenaya
      • Las Vegas, Nevada, 미국, 89128
        • Ann M Wierman MD LTD
      • Las Vegas, Nevada, 미국, 89102
        • OptumCare Cancer Care at Oakey
    • New Mexico
      • Albuquerque, New Mexico, 미국, 87102
        • University of New Mexico Cancer Center
      • Las Cruces, New Mexico, 미국, 88011
        • Memorial Medical Center - Las Cruces
    • New York
      • The Bronx, New York, 미국, 10461
        • Montefiore Medical Center-Einstein Campus
      • The Bronx, New York, 미국, 10467
        • Montefiore Medical Center - Moses Campus
      • The Bronx, New York, 미국, 10461
        • Montefiore Medical Center-Weiler Hospital
    • North Dakota
      • Bismarck, North Dakota, 미국, 58501
        • Sanford Bismarck Medical Center
      • Fargo, North Dakota, 미국, 58122
        • Sanford Roger Maris Cancer Center
      • Fargo, North Dakota, 미국, 58122
        • Sanford Broadway Medical Center
    • Ohio
      • Belpre, Ohio, 미국, 45714
        • Strecker Cancer Center-Belpre
      • Chillicothe, Ohio, 미국, 45601
        • Adena Regional Medical Center
      • Columbus, Ohio, 미국, 43219
        • The Mark H Zangmeister Center
      • Columbus, Ohio, 미국, 43214
        • Columbus Oncology and Hematology Associates Inc
      • Marietta, Ohio, 미국, 45750
        • Marietta Memorial Hospital
      • Mount Vernon, Ohio, 미국, 43050
        • Knox Community Hospital
      • Newark, Ohio, 미국, 43055
        • Licking Memorial Hospital
      • Portsmouth, Ohio, 미국, 45662
        • Southern Ohio Medical Center
    • Oregon
      • Clackamas, Oregon, 미국, 97015
        • Clackamas Radiation Oncology Center
      • Clackamas, Oregon, 미국, 97015
        • Providence Cancer Institute Clackamas Clinic
      • Newberg, Oregon, 미국, 97132
        • Providence Newberg Medical Center
      • Portland, Oregon, 미국, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, 미국, 97225
        • Providence Saint Vincent Medical Center
    • Pennsylvania
      • Paoli, Pennsylvania, 미국, 19301
        • Paoli Memorial Hospital
      • Wynnewood, Pennsylvania, 미국, 19096
        • Lankenau Medical Center
    • South Carolina
      • Anderson, South Carolina, 미국, 29621
        • AnMed Health Cancer Center
      • Charleston, South Carolina, 미국, 29425
        • Medical University of South Carolina
      • Greer, South Carolina, 미국, 29651
        • Gibbs Cancer Center-Pelham
      • Spartanburg, South Carolina, 미국, 29303
        • Spartanburg Medical Center
    • South Dakota
      • Sioux Falls, South Dakota, 미국, 57117-5134
        • Sanford USD Medical Center - Sioux Falls
      • Sioux Falls, South Dakota, 미국, 57104
        • Sanford Cancer Center Oncology Clinic
    • Tennessee
      • Memphis, Tennessee, 미국, 38120
        • Baptist Memorial Hospital and Cancer Center-Memphis
      • Nashville, Tennessee, 미국, 37208
        • Meharry Medical College
    • Virginia
      • Richmond, Virginia, 미국, 23298
        • Virginia Commonwealth University/Massey Cancer Center
    • Washington
      • Auburn, Washington, 미국, 98001
        • MultiCare Auburn Medical Center
      • Gig Harbor, Washington, 미국, 98335
        • MultiCare Gig Harbor Medical Park
      • Puyallup, Washington, 미국, 98372
        • MultiCare Good Samaritan Hospital
      • Tacoma, Washington, 미국, 98405
        • MultiCare Tacoma General Hospital
    • Wisconsin
      • Burlington, Wisconsin, 미국, 53105
        • Aurora Cancer Care-Southern Lakes VLCC
      • Fond du Lac, Wisconsin, 미국, 54937
        • Aurora Health Center-Fond du Lac
      • Grafton, Wisconsin, 미국, 53024
        • Aurora Cancer Care-Grafton
      • Green Bay, Wisconsin, 미국, 54311
        • Aurora BayCare Medical Center
      • Kenosha, Wisconsin, 미국, 53142
        • Aurora Cancer Care-Kenosha South
      • Milwaukee, Wisconsin, 미국, 53209
        • Aurora Cancer Care-Milwaukee
      • Milwaukee, Wisconsin, 미국, 53215
        • Aurora Saint Luke's Medical Center
      • New Richmond, Wisconsin, 미국, 54017
        • Cancer Center of Western Wisconsin
      • Oshkosh, Wisconsin, 미국, 54904
        • Vince Lombardi Cancer Clinic - Oshkosh
      • Sheboygan, Wisconsin, 미국, 53081
        • Vince Lombardi Cancer Clinic-Sheboygan
      • Summit, Wisconsin, 미국, 53066
        • Aurora Medical Center in Summit
      • Two Rivers, Wisconsin, 미국, 54241
        • Vince Lombardi Cancer Clinic-Two Rivers
      • Wauwatosa, Wisconsin, 미국, 53226
        • Aurora Cancer Care-Milwaukee West
      • West Allis, Wisconsin, 미국, 53227
        • Aurora West Allis Medical Center
    • Wyoming
      • Cheyenne, Wyoming, 미국, 82001
        • Cheyenne Regional Medical Center-West

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

15년 (어린이, 성인)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

여성

설명

Inclusion Criteria:

  • Female patients presenting with initial diagnosis of any type of cancer, including patients with ductal carcinoma in situ (DCIS)

  • Pre-menopausal patients within the reproductive age range of 15-55 years; pre-menopausal is defined as females meeting the following criteria:

    • Patients not currently on hormonal contraception with the presence of menses in the past 6 months
    • If no menstruation in the past 6 months, without hormonal manipulation, then confirmed follicle-stimulating hormone (FSH) < 23mlU/mL
    • If age < 47 years and on hormonal contraception, then patient will be eligible regardless of menstrual history
    • If age ≥ 47 years and on hormonal contraception, then FSH confirmed < 23mIU/mL

  • Pregnant women are eligible to participate in this study

  • Patients must have the cognitive ability to participate in the study

Exclusion Criteria:

  • Patients who have initiated chemotherapy, radiation therapy or endocrine therapy prior to registration to this study
  • Prior hysterectomy, bilateral oophorectomy or sterilization of any method

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 지지 요법
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: Arm A (no intervention)

Patients undergo usual standard practice related to reproductive health.
다른: Standard practice related to reproductive heath

Patients undergo usual standard practice related to reproductive health.
실험적: Arm B (reproductive health program)

Patients undergo reproductive health program comprising didactics, reproductive health assessment and navigating algorithm, and network development.
다른: Training modules, algorithm, referral development

Patients undergo reproductive health program comprising didactics, reproductive health assessment and navigating algorithm, and network development.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Proportion of Patients With Appropriate Reproductive Health Management
기간: At baseline and 3 months

Appropriate reproductive health management was determined using the followings: (1) Females that were pregnant or interested in immediate pregnancy (defined as within 1 year of enrollment) were given referral to obstetrician/gynecologist or counseled about pregnancy options (2) Females interested in future childbearing were counseled or given a referral for fertility preservation if requested (3) Females who were not interested in immediate pregnancy were given a referral or counseling to select family planning that was consistent with plans for sexual activity and future childbearing. If a female fell into category 1, 2, or 3, and the appropriate referral occurred within 3 months of enrollment, then appropriate reproductive health management was achieved. For patients with appropriate reproductive health management in place before the baseline visit, they were included in the analysis and counted as having appropriate reproductive health management.
At baseline and 3 months

2차 결과 측정

결과 측정
측정값 설명
기간
Difference in Rating Between Patients and Their Clinicians in Importance of Fertility Maintenance
기간: At baseline

The rating on the importance of fertility maintenance was assessed among patients and the corresponding treating physicians. The rating scale ranges between 1 and 10. Higher scores indicate more importance of fertility maintenance. The difference in rating was calculated by subtracting patient rating from physician's rating.
At baseline
The Changes in Reproductive Health Status From Baseline to 3 Months
기간: Baseline and 3 months

Patient's reproductive health choices relating to oncofertility, oncocontraception and pregnancy was assessed at baseline and 3 months. Patient's reproductive health status is categorized into the following categories:

  • Sextually active & childbearing not completed
  • Sextually active & childbearing completed
  • Sextually not active & childbearing not completed
  • Sextually not active & childbearing completed
  • Sexuality unknown & childbearing not completed
  • Sexuality unknown & childbearing completed
  • Pregnant/Pregnancy in 1 year
  • Missing/Unknown
Baseline and 3 months
Associations Between Clinical and Demographic Factors and Adequacy of Reproductive Health Care Management
기간: Baseline and 3 months

Appropriate reproductive health management was determined using the followings: (1) Females that were pregnant or interested in immediate pregnancy (defined as within 1 year of enrollment) were given referral to obstetrician/gynecologist or counseled about pregnancy options (2) Females interested in future childbearing were counseled or given a referral for fertility preservation if requested (3) Females who were not interested in immediate pregnancy were given a referral or counseling to select family planning that was consistent with plans for sexual activity and future childbearing. If a female fell into category 1, 2, or 3, and the appropriate referral occurred within 3 months of enrollment, then appropriate reproductive health management was achieved. For patients with appropriate reproductive health management in place before the baseline visit, they were included in the analysis and counted as having appropriate reproductive health management.
Baseline and 3 months

기타 결과 측정

결과 측정
측정값 설명
기간
Levels of Endocrine Markers of Fertility
기간: Baseline and 3, 6, 12, 24 months

Reproductive health-related biomarkers, including follicle-stimulating hormone (FSH), anti-müllerian hormone (AMH), thyroid stimulating hormone (TSH) and Thyroid peroxidase (TPO), were evaluated through blood samples collected at baseline and 3, 6, 12, 24 months.
Baseline and 3, 6, 12, 24 months
Sexual Function Score by Patient-Reported Outcomes Measurement Information System (PROMIS)
기간: Baseline and 3, 6, 12, 24 months

Sexual function was evaluated using PROMIS sexual function survey brief profile V1.0. All subdomain scores (except for the orgasm subdomain) are expressed as T-scores with a mean of 50 and a standard deviation of 10. A raw summed score is created for each domain. For Global Satisfaction with Sex Life, the raw summed score can range from 2 (endorsed "Not at all" to both items) to 10 (endorsed "Very" or "Very much" to both items). Higher scores indicate more satisfaction/interest/lubrication/discomfort/ability with sex life. Lower scores indicate less satisfaction/interest/lubrication/discomfort/ability with sex life.
Baseline and 3, 6, 12, 24 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

ECOG-ACRIN Cancer Research Group

협력자

National Cancer Institute (NCI)

수사관

  • 수석 연구원: Ashlesha Patel, Eastern Cooperative Oncology Group

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2016년 9월 2일

기본 완료 (실제)

2021년 7월 31일

연구 완료 (추정된)

2026년 12월 31일

연구 등록 날짜

최초 제출

2013년 2월 19일

QC 기준을 충족하는 최초 제출

2013년 3월 5일

처음 게시됨 (추정된)

2013년 3월 7일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 10월 6일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 14일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

키워드

추가 관련 MeSH 약관

기타 연구 ID 번호

  • E1Q11
  • U10CA037403 (미국 NIH 보조금/계약)
  • NCI-2012-02869 (레지스트리 식별자: CTRP (Clinical Trial Reporting Program))

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

Individual participant data may be made available upon request as per the ECOG-ACRIN Data Sharing Policy.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다